Lin Yang1, Li-Juan Yuan1, Rui Dong1, Ji-Kai Yin1, Qing Wang1, Tao Li1, Jiang-Bin Li1, Xi-Lin Du1, Jian-Guo Lu1. 1. Lin Yang, Li-Juan Yuan, Rui Dong, Ji-Kai Yin, Qing Wang, Tao Li, Jiang-Bin Li, Xi-Lin Du, Jian-Guo Lu, Department of General Surgery, Tangdu Hospital of the Fourth Military Medical University, Xi'an 710038, Shannxi Province, China.
Abstract
AIM: To determine the clinical value of a splenorenal shunt plus pericardial devascularization (PCVD) in portal hypertension (PHT) patients with variceal bleeding. METHODS: From January 2008 to November 2012, 290 patients with cirrhotic portal hypertension were treated surgically in our department for the prevention of gastroesophageal variceal bleeding: 207 patients received a routine PCVD procedure (PCVD group), and 83 patients received a PCVD plus a splenorenal shunt procedure (combined group). Changes in hemodynamic parameters, rebleeding, encephalopathy, portal vein thrombosis, and mortality were analyzed. RESULTS: The free portal pressure decreased to 21.43 ± 4.35 mmHg in the combined group compared with 24.61 ± 5.42 mmHg in the PCVD group (P < 0.05). The changes in hemodynamic parameters were more significant in the combined group (P < 0.05). The long-term rebleeding rate was 7.22% in the combined group, which was lower than that in the PCVD group (14.93%), (P < 0.05). CONCLUSION: Devascularization plus splenorenal shunt is an effective and safe strategy to control esophagogastric variceal bleeding in PHT. It should be recommended as a first-line treatment for preventing bleeding in PHT patients when surgical interventions are considered.
AIM: To determine the clinical value of a splenorenal shunt plus pericardial devascularization (PCVD) in portal hypertension (PHT) patients with variceal bleeding. METHODS: From January 2008 to November 2012, 290 patients with cirrhotic portal hypertension were treated surgically in our department for the prevention of gastroesophageal variceal bleeding: 207 patients received a routine PCVD procedure (PCVD group), and 83 patients received a PCVD plus a splenorenal shunt procedure (combined group). Changes in hemodynamic parameters, rebleeding, encephalopathy, portal vein thrombosis, and mortality were analyzed. RESULTS: The free portal pressure decreased to 21.43 ± 4.35 mmHg in the combined group compared with 24.61 ± 5.42 mmHg in the PCVD group (P < 0.05). The changes in hemodynamic parameters were more significant in the combined group (P < 0.05). The long-term rebleeding rate was 7.22% in the combined group, which was lower than that in the PCVD group (14.93%), (P < 0.05). CONCLUSION: Devascularization plus splenorenal shunt is an effective and safe strategy to control esophagogastric variceal bleeding in PHT. It should be recommended as a first-line treatment for preventing bleeding in PHT patients when surgical interventions are considered.
Authors: M Johnson; S Rajendran; T G Balachandar; D Kannan; S Jeswanth; P Ravichandran; R Surendran Journal: World J Surg Date: 2006-08 Impact factor: 3.352
Authors: Joaquin Poza Cordon; Consuelo Froilan Torres; Aurora Burgos García; Francisco Gea Rodriguez; Jose Manuel Suárez de Parga Journal: World J Gastrointest Endosc Date: 2012-07-16
Authors: J Michael Henderson; Thomas D Boyer; Michael H Kutner; John R Galloway; Layton F Rikkers; Lennox J Jeffers; Kareem Abu-Elmagd; Jason Connor Journal: Gastroenterology Date: 2006-05 Impact factor: 22.682
Authors: Alexander S Rosemurgy; Emmanuel E Zervos; Mark Bloomston; Alan J Durkin; Whalen C Clark; Stephanie Goff Journal: Ann Surg Date: 2003-06 Impact factor: 12.969
Authors: Ya-Fei Zhang; Hong Ji; Hong-Wei Lu; Le Lu; Lei Wang; Jin-Long Wang; Yi-Ming Li Journal: World J Clin Cases Date: 2018-06-16 Impact factor: 1.337
Authors: Yin Jikai; Wang Dong; Zhang Li; Dong Rui; Yang Tao; Huang Bo; Sun Yibo; Lei Shixiong; Bai Qiangshan; Lu Jianguo Journal: Front Surg Date: 2022-08-10